Pharmacokinetic (PK) and phase I study of sorafenib (S) for solid tumors and hematologic malignancies in patients with hepatic or renal dysfunction (HD or RD): CALGB 60301
- Citation:
- J Clin Oncol vol 25 (18s) abstr
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 197
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- A. A. Miller D. J. Murry K. Owzar D. R. Hollis G. K. Abou-Alfa A. Desai J. J. Hwang M. A. Villalona-Calero E. C. Dees M. J. Ratain
- Networks:
- Study
- CALGB-60301
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1
- Keywords: